SS2-adrenoceptor agonist for improvement of exercise tolerance
AssigneeBoehringer Ingelheim International GmbH
InventorAlan HAMILTON
Life of this patent
Estimating the term…
Abstract
This invention relates to the β2-adrenoceptor agonist Olodaterol or a pharmaceutically acceptable salt thereof, for use in a method of treatment for improvement of exercise tolerance and/or in an improvement of endurance time.
Claims12
A method of improving exercise tolerance and/or endurance time in a patient with COPD comprising administering to the patient a therapeutically effective amount of olodaterol or a pharmaceutically acceptable salt thereof.
The method according to claim 2, wherein said method comprises administering olodaterol hydrochloride to the patient.
A method of improving exercise tolerance and/or endurance time in a patient with COPD comprising administering to the patient a pharmaceutical composition comprising olodaterol or a pharmaceutically acceptable salt thereof and a tiotropium salt.
Dependencies are inferred from the claim text.